Sign up

Newtyn Management, LLC

$800.9M assets · 34 holdings · Q2 2026 · Filed 14 AUG 2026

About Newtyn Management, LLC’s 13F portfolio

Newtyn Management, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Newtyn Management, LLC reported $800.9M across 34 US-listed positions (). Its largest position is QUIDELORTHO CORP (QDEL) at 14% of the reported book, and its ten biggest holdings make up 62% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$800.9M
Assets (13F)
#2,727
of 8,839 by size
34
Holdings
62%
Top-10 weight
15
Buys
20
Sells
Top holdings · Q2 2026
34 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: QDEL
QUIDELORTHO CORP
$9.57
−3.04%
14%
6.6M$116.0M
2
NASDAQ: TBPH
THERAVANCE BIOPHARMA INC
$17.03
0.00%
7.3%
3.4M$58.4M
3
NASDAQ: INDV
INDIVIOR PHARMACEUTICALS INC
$26.74
−5.21%
6.7%
1.3M$53.6M
4
NYSE: CNNE
CANNAE HLDGS INC
$17.50
+2.64%
5.7%
3.2M$45.6M
5
NYSE: PAR
PAR TECHNOLOGY CORP
$22.94
+2.59%
5.3%
2.4M$42.1M
6
NYSE: WEAV
WEAVE COMMUNICATIONS INC
$7.40
+0.14%
5.1%
6.8M$40.7M
7
NYSE: TFX
TELEFLEX INCORPORATED
$165.85
+3.95%
4.8%
305K$38.7M
8
NYSE: AIV
APARTMENT INVT & MGMT CO
$1.40
−0.71%
4.5%
12.2M$36.2M
9
NYSE: MAGN
MAGNERA CORP
$11.91
−0.92%
4.1%
2.8M$32.9M
10
NASDAQ: OCTV
OCTAVE INTELLIGENCE PLC
—
—
3.9%
1.9M$31.3M
11
NASDAQ: XOMA
XOMA ROYALTY CORPORATION
$40.17
0.00%
3.8%
709K$30.1M
12
NYSE: RHLD
RESOLUTE HLDGS MGMT INC
$147.78
+1.73%
3.7%
202K$29.3M
13
NYSE: BV
BRIGHTVIEW HLDGS INC
$8.81
+0.46%
3.4%
1.9M$27.5M
14
NASDAQ: PPSI
POWER SOLUTIONS INTL INC
$2.15
−0.46%
2.9%
601K$23.4M
15
NASDAQ: CCOI
COGENT COMM HOLDINGS INC
$3.18
+0.16%
2.9%
1.7M$23.0M
16
NYSE: AD
ARRAY DIGITAL INFRASTRUCTURE
$27.00
−0.81%
2.7%
597K$21.7M
17
NYSE: CMP
COMPASS MINERALS INTL INC
$20.51
−3.80%
2.5%
632K$19.7M
18
NYSE: GDOT
GREEN DOT CORP
$11.40
−1.81%
2.0%
1.2M$16.3M
19
NYSE: SPB
SPECTRUM BRANDS HOLDINGS INC
$82.04
+1.12%
2.0%
185K$15.9M
20
NYSE: XRN
CHIRON REAL ESTATE INC
—
—
1.9%
406K$15.2M
21
NASDAQ: RCKT
ROCKET PHARMACEUTICALS INC
$2.11
0.00%
1.7%
4.0M$13.7M
22
NASDAQ: FLWS
1 800 FLOWERS COM INC
$1.99
+2.84%
1.5%
3.5M$12.2M
23
NASDAQ: NODK
NI HLDGS INC
$14.90
+0.88%
1.3%
670K$10.5M
24
NASDAQ: GRAL
GRAIL INC
$102.10
−3.57%
1.3%
150K$10.2M
25
NYSE: NVRI
ENVIRI CORP
$23.77
−1.86%
1.0%
374K$8.2M

Showing 1–25 of 34 positions on this page reported in this 13F.

Sector allocation
  • Healthcare46%
  • Industrials11%
  • Consumer Cyclical7.2%
  • Real Estate6.2%
  • Consumer Defensive6.1%
  • Communication Services5.6%
  • Technology5.3%
  • Financial Services3.3%
  • Basic Materials2.5%
Recent activity · vs 2026-03-31
Bought15
  • AddedQDELQUIDELORTHO CORP+45.3%$116.0M
  • AddedMAGNMAGNERA CORP+1.4%$32.9M
  • NewOCTVOCTAVE INTELLIGENCE PLC—$31.3M
  • NewXOMAXOMA ROYALTY CORPORATION—$30.1M
  • NewPPSIPOWER SOLUTIONS INTL INC—$23.4M
  • AddedCCOICOGENT COMM HOLDINGS INC+3.5%$23.0M
  • AddedGDOTGREEN DOT CORP+744%$16.3M
  • NewXRNCHIRON REAL ESTATE INC—$15.2M
  • AddedRCKTROCKET PHARMACEUTICALS INC+26.3%$13.7M
  • NewNVRIENVIRI CORP—$8.2M
Sold20
  • ReducedTBPHTHERAVANCE BIOPHARMA INC−29.1%$58.4M
  • ReducedINDVINDIVIOR PHARMACEUTICALS INC−34.7%$53.6M
  • ReducedCNNECANNAE HLDGS INC−3.0%$45.6M
  • ReducedPARPAR TECHNOLOGY CORP−11.5%$42.1M
  • ReducedWEAVWEAVE COMMUNICATIONS INC−3.0%$40.7M
  • ReducedTFXTELEFLEX INCORPORATED−23.8%$38.7M
  • ReducedRHLDRESOLUTE HLDGS MGMT INC−16.5%$29.3M
  • ReducedBVBRIGHTVIEW HLDGS INC−7.6%$27.5M
  • ReducedADARRAY DIGITAL INFRASTRUCTURE−63.1%$21.7M
  • ReducedCMPCOMPASS MINERALS INTL INC−17.9%$19.7M
5%+ Beneficial Ownership Stakes · 9 passive (13G)

Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.

#StockType% of classSharesFiled
1
ZOOZ
ZOOZ Strategy Ltd.
13G8.6%13.9MFiled 17 FEB 2026
2
TBPH
Theravance Biopharma, Inc.
13G8.5%4.3MFiled 17 FEB 2026
3
AIV
APARTMENT INVESTMENT & MANAGEMENT CO
13G8.1% · 2 classes11.6MFiled 25 MAR 2026
4
QDEL
QuidelOrtho Corporation
13G7.8%5.3MFiled 16 NOV 2026
5
MAGN
Magnera Corporation
13G7.7% · 2 classes2.8MFiled 15 MAY 2026
6
CNNE
Cannae Holdings, Inc.
13G7.6% · 2 classes3.5MFiled 17 FEB 2026
7
—
City Office Reit, Inc.
13G6.9%2.8MFiled 17 FEB 2026
8
NVRI
Enviri Corp
13G6.2%5.0MFiled 17 FEB 2026
9
SRG
Seritage Growth Properties
13G5.4%3.0MFiled 16 NOV 2026

Showing all 9 disclosed stakes.

Reading Newtyn Management, LLC’s 13F portfolio

Newtyn Management, LLC’s $800.9M 13F book is spread across 34 reported positions and is highly concentrated — its ten largest positions alone are 62% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are QDEL, TBPH, INDV, CNNE and PAR, led by QUIDELORTHO CORP (QDEL) at 14% of the portfolio. The heaviest sector exposure is Healthcare (46%), then Industrials (11%).

What Newtyn Management, LLC changed last quarter

Between 2026-03-31 and Q2 2026, Newtyn Management, LLC was a net seller: it opened 8 new positions and added to 7 more, while trimming 13 and closing 7 outright. Against a 34-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was QUIDELORTHO CORP (QDEL), and its biggest reduction was THERAVANCE BIOPHARMA INC (TBPH).

What a 13F does and doesn’t reveal

A 13F captures only Newtyn Management, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Newtyn Management, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Newtyn Management, LLC's profile on this page is built directly from those filings.

How current is the 13F data on Newtyn Management, LLC's page?

It reflects Newtyn Management, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Newtyn Management, LLC files its next quarterly report, this page refreshes automatically.

Can I see Newtyn Management, LLC's complete list of holdings?

This page highlights Newtyn Management, LLC's largest positions rather than all 34 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Newtyn Management, LLC's filings.

Does a 13F show everything Newtyn Management, LLC owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Newtyn Management, LLC's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Newtyn Management, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.